BioSpace News Archive

Global Cord Blood Corporation announced that the Company filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission.

Windtree Therapeutics today announced that it has successfully completed design verification of its new proprietary aerosol delivery system (ADS) for AEROSURF®.

Celgene today announced results from a phase III, randomized, double-blind, international clinical study (AUGMENT). REVLIMID® (lenalidomide) plus rituximab (R2) achieved a highly statistically significant improvement in the primary endpoint of progression-free survival (PFS), compared to rituximab plus placebo, in the final PFS analysis.

Today the U.S. House of Representatives voted to pass the National Suicide Hotline Improvement Act. The Senate unanimously passed the same bill in October 2017. John Madigan, senior vice president for public policy from the American Foundation for Suicide Prevention (AFSP), the nation’s largest suicide prevention organization, released this statement:

New research advances the diagnosis of concussions and PTSD for those in the line of duty

Cipher Pharmaceuticals Inc. announced the details of its Q2 2018 financial results conference call on Friday, August 10, 2018.

Fletcher Spaght Inc. (FSI) is proudly celebrating 35 years as a leader in growth-focused strategy consulting centered on innovation and accelerating organic and inorganic growth within the global healthcare and technology industries.

Revenue up 24% to $22.8 Million Compared to Second Quarter 2017

The ever-changing Anthony F. Markel Family City of Hope Museum was named in honor of an insurance industry leader and his family

Ironwood Pharmaceuticals, Inc. announced it will host its second quarter 2018 investor update conference call and webcast at 8:30 a.m. Eastern Time on Monday, August 6, 2018.